Abstract: According to one embodiment, an apparatus is disclosed. The apparatus includes an endoscopic clip placement tool and one or more marking clips attached to a specimen mass by the clip placement tool to mark a margin and orientation of the specimen mass.

Abstract: A locking mechanism includes a lock housing and an activation shaft. The lock housing defines first and second axes, each being different than the other. The lock housing includes an inner mechanism housing wall, a hollow conduit defined by the inner mechanism housing wall, and a channel. The channel is defined by a portion of the inner mechanism housing wall and has first and second portions, where the first portion extends along the first axis and the second portion extends along the second axis. The activation shaft is at least partially surrounded by the hollow conduit and includes a shoulder protruding from the activation shaft towards the channel of the inner mechanism housing wall. In an unlock position, the shoulder is freely manipulatable within the first portion of the channel along the first axis, and in a lock position the shoulder is prevented from moving along the first axis.

Abstract: Novel peptides are disclosed with their use as a pharmaceutical composition. A method is also disclosed for making pharmaceutical compositions and treatment of an individual.

Abstract: Novel peptides are disclosed with their use as a pharmaceutical composition. A method is also disclosed for making pharmaceutical compositions and treatment of an individual.

Abstract: A process for making a solid component out of recycled powder coat is provided. The process can include providing a powder coat material and providing a second material. Thereafter, the powder coat and the second material are mixed to produce a powder coat-second material mixture. The powder coal-second material mixture is processed in order to produce a polymer containing precursor. The processing can include granulating or densifying the powder coat-second material mixture. After the precursor has been produced, it can be placed within a molding machine and a solid component is molded. The molding machine can be an injection molding machine, an extrusion molding machine or a blow molding machine.

Abstract: A locking mechanism includes a lock housing and an activation shaft. The lock housing defines first and second axes, each being different than the other. The lock housing includes an inner mechanism housing wall, a hollow conduit defined by the inner mechanism housing wall, and a channel. The channel is defined by a portion of the inner mechanism housing wall and has first and second portions, where the first portion extends along the first axis and the second portion extends along the second axis. The activation shaft is at least partially surrounded by the hollow conduit and includes a shoulder protruding from the activation shaft towards the channel of the inner mechanism housing wall. In an unlock position, the shoulder is freely manipulatable within the first portion of the channel along the first axis, and in a lock position the shoulder is prevented from moving along the first axis.

Abstract: Novel peptides are disclosed with their use as a pharmaceutical composition. A method is also disclosed for making pharmaceutical compositions and treatment of an individual.

Abstract: A fastener is disclosed. The fastener includes a housing, a cage, a plurality retaining members and a plunger. The plunger is at least partially movable within said cage between a first position to cause said one or more retaining members to be displaced radially outwardly thereby mechanically coupling said housing to said cage, and a second position to allow said one or more retaining members to be displaced radially inwardly thereby allowing said housing to be uncoupled from said cage.

Abstract: Novel peptides are disclosed with their use as a pharmaceutical composition. A method is also disclosed for making pharmaceutical compositions and treatment of an individual.

Abstract: Novel peptides are disclosed with their use as a pharmaceutical composition. A method is also disclosed for making pharmaceutical compositions and treatment of an individual.

Abstract: A fastener is disclosed. The fastener includes a housing, a cage, a plurality of retaining members and a plunger. The plunger is at least partially movable within said cage between a first position to cause said one or more retaining members to be displaced radially outwardly thereby mechanically coupling said housing to said cage, and a second position to allow said one or more retaining members to be displaced radially inwardly thereby allowing said housing to be uncoupled from said cage.

Abstract: A fastener is disclosed. The fastener includes a housing, wherein the housing forms a housing cavity, wherein the housing cavity includes at least one recess; a cage at least partially disposed in said housing cavity, wherein an outer surface of the cage is spaced apart from an inner surface of the housing that forms the housing cavity, wherein the cage defines a cage cavity, and a plurality of passages aligned with said at least one recess; a plurality of retaining members at least partially retained within said plurality of passages; and a plunger at least partially disposed in said cage cavity, wherein said plunger is at least partially movable within said cage cavity between a first position to cause said one or more retaining members to be displaced radially outwardly thereby mechanically coupling said housing to said cage, and a second position to allow said one or more retaining members to be displaced radially inwardly thereby allowing said housing to be uncoupled from said cage.

Abstract: Novel peptides are disclosed with their use as a pharmaceutical composition. A method is also disclosed for making pharmaceutical compositions and treatment of an individual.

Abstract: Thirty substantially pure and biologically active peptides are disclosed. Nucleic acids that have sequences coding for the biologically active peptides and pharmaceutical formulations produced therefrom are also disclosed.

Abstract: Peptides derived from the peptide CMS-010, which has the formula VAPEEHPTLLTEAPLNPK, are disclosed with their use as pharmaceutical compositions. A method is also disclosed for making a pharmaceutical composition comprising providing a peptide derived from CMS-010 and mixing said peptide with a pharmaceutical acceptable carrier.

Abstract: A substantially pure and biologically active peptides consisting of tyrosyl-seryl-leucine (YSL) is disclosed. Nucleic acids that have sequences coding for the biologically active peptide and pharmaceutical formulation produced therefrom are also disclosed.

Abstract: The tripeptide Tyrosyl-seryl-valine is disclosed with its use as a nutritional supplement. A method of making a nutritional supplement comprising obtaining the tripeptide Tyrosyl-seryl-valine and mixing the tripeptide with a biologically or therapeutically acceptable carrier is also disclosed.

Abstract: Thirty substantially pure and biologically active peptides are disclosed. Nucleic acids that have sequences coding for the biologically active peptides and pharmaceutical formulations produced thereform are also disclosed.